NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report

NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report

Background: NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efficacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants are hetero...

Full description

Bibliographic Details
Published in:Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Main Author: Abdul Rashid A.M.; Md Noh M.S.F.; Yusof Khan A.H.K.; Loh W.C.; Baharin J.; Ibrahim A.; Inche Mat L.N.; Wan Sulaiman W.A.; Hoo F.K.; Hanapiah F.A.; Basri H.
Format: Article
Language:English
Published: Springer Science and Business Media Deutschland GmbH 2021
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118709264&doi=10.1186%2fs41983-021-00397-y&partnerID=40&md5=9c8be29816f02c4acfe1f691dcacc623

Internet

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118709264&doi=10.1186%2fs41983-021-00397-y&partnerID=40&md5=9c8be29816f02c4acfe1f691dcacc623

Similar Items